Neurosteroids — Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy
about
Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural formsFragile X-associated tremor/ataxia syndrome.Interictal spike frequency varies with ovarian cycle stage in a rat model of epilepsyTonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy.Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autismThe GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome.Rapid Throughput Analysis of GABAA Receptor Subtype Modulators and Blockers Using DiSBAC1(3) Membrane Potential Red Dye.Sex, epilepsy, and epigenetics.Sex differences in the neurobiology of epilepsy: a preclinical perspective.Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures.Tetramethylenedisulfotetramine alters Ca²⁺ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulationNeurosteroid Deficiency Associated With Epilepsy.Brain-derived neurotrophic factor-estrogen interactions in the hippocampal mossy fiber pathway: implications for normal brain function and disease.Limbic networks and epileptiform synchronization: the view from the experimental side.Neuroactive steroids for the treatment of status epilepticusNeurosteroids differentially modulate fast and slow interictal discharges in the hippocampal CA3 area.Neurosteroidal modulation of in vitro epileptiform activity is enhanced in pilocarpine-treated epileptic rats.Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy.A novel therapeutic approach for treatment of catamenial epilepsy.
P2860
Q24564596-2E8D1AB5-846F-483F-A0C1-93494784B130Q26852667-A5C61661-099C-4BD1-BFF2-48724E8F4A68Q27311376-4A4312E2-ACCA-4F27-8B5C-66F9380C62E1Q27692644-C55091E7-8349-4A9A-9E12-E7434213816BQ28383216-A511FB94-DBA3-46F9-BCE5-97035327A87FQ30385019-5DF8357C-4401-4AAC-8920-033B46B4D3BFQ34555539-08C1B118-286C-47F3-857F-8700D5580956Q34613797-07429E6F-FB81-493B-ABA1-8A6F7F36ADFEQ34616106-298AF0A6-94E6-4421-8468-50FB1EDBB130Q35738618-BEA7384C-080F-4564-8B1F-F8B2D7C4EAA0Q36486976-C0D73055-34AF-4EFB-BD09-B6249C99EA06Q36771157-0AC0690A-3247-4248-8538-3B581729BA94Q36771911-413E9DCA-8128-46C7-B103-80BBE920BD84Q36932154-B453E8F8-DD92-4D01-A22D-D2197AA854E5Q37169261-1E73191F-B894-412E-A8D3-9C30BAC9D3C7Q41946293-07E360FD-38F0-4DE8-BC4D-960F4736CF9FQ42761640-72D5E82B-7EDD-46F8-A5BC-8D10D524B170Q47967839-207C389F-739F-4B4C-A580-C2A893B68E39Q49598739-FE7E6F95-892A-4744-B534-B9D577D6C525
P2860
Neurosteroids — Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@ast
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@en
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@nl
type
label
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@ast
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@en
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@nl
prefLabel
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@ast
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@en
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@nl
P1476
Neurosteroids — Endogenous Reg ...... e in the Treatment of Epilepsy
@en
P2093
P407
P577
2012-01-01T00:00:00Z